Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Total Debt (2021)

Historic Total Debt for Barinthus Biotherapeutics (BRNS) over the last 1 years, with Q4 2021 value amounting to $159000.0.

  • Barinthus Biotherapeutics' Total Debt changed N/A to $159000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $159000.0, marking a year-over-year change of. This contributed to the annual value of $159000.0 for FY2021, which is N/A changed from last year.
  • Barinthus Biotherapeutics' Total Debt amounted to $159000.0 in Q4 2021.
  • In the past 5 years, Barinthus Biotherapeutics' Total Debt ranged from a high of $159000.0 in Q4 2021 and a low of $159000.0 during Q4 2021